Increased NF-κB activity is associated with TMZ-resistance in glioma64, radioresistance of glioblastoma stem cells41, and inhibition of NF-κB activity in combination with temozolomide significantly improved glioma treatment outcome65. The gene discussed is NFKB1; the disease is glioma.